Stereotactic Radiosurgery Alone Better for Cognition in Brain Metastases
Intracranial disease control at 3 months was better with combination therapy; however it did not appear to impact overall survival.
Intracranial disease control at 3 months was better with combination therapy; however it did not appear to impact overall survival.
GTR increases survival by about 61% at 1 year compared to STR.
Researchers achieved a 3-year event-free survival rate of 73.2% for tandem transplant patients.
The role of antiangiogenic agents continues to evolve in the treatment of CNS cancers.
Researchers were able to identify 8 genes that showed the highest association to outcomes.
Multiple modalities were found to be superior to single modality therapies in elderly patients with glioblastoma.
Interestingly, the risk of death and tumor progression was increased in low-grade gliomas.
Those who received both treatments lived longer than those who received radiation alone.
Focal cooling is a vast improvement over older brain-mapping techniques, which risked triggering epileptic seizures during surgery.
Over 10 000 brain and CNS tumors are diagnosed in adolescent and young adults each year.